By downregulating the NKG2D ligand crucial for the NKG2D-mediated response of NK cells, IFN-γ facilitates immune escape of major histocompatibility complex-I (MHC-I)-negative melanoma cells [18]. The gene discussed is IFNG; the disease is melanoma.